XOMA
Xoma Royalty Corporation
NASDAQ · Biotechnology
$24.86
-0.06 (-0.24%)
Open$25.41
Previous Close$24.92
Day High$26.29
Day Low$24.77
52W High$44.90
52W Low$22.24
Volume—
Avg Volume778.0K
Market Cap345.36M
P/E Ratio34.50
EPS$1.12
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+61.0% upside
Current
$24.86
$24.86
Target
$40.02
$40.02
$30.13
$40.02 avg
$66.99
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 45.07M | 45.56M | 48.20M |
| Net Income | -2,126,496 | -2,452,418 | -2,537,562 |
| Profit Margin | -4.7% | -5.4% | -5.3% |
| EBITDA | -3,149,560 | -2,902,540 | -2,951,728 |
| Free Cash Flow | -1,725,404 | -1,967,070 | -1,836,225 |
| Rev Growth | -2.0% | +14.7% | +11.9% |
| Debt/Equity | 0.37 | 0.37 | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |